Jason R Kelly Ginkgo Bioworks Holdings, Inc. (DNA) insider trading activity

Jason R Kelly is Director of Ginkgo Bioworks Holdings, Inc.. Currently has a direct ownership of 3.89 Million shares of DNA, which is worth approximately $24.3 Million. The most recent transaction as insider was on Jan 04, 2024, when has been sold 100,000 shares (Class A Common Stock) at a price of $1.55 per share, resulting in proceeds of $155,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.89M

0% 3M change

45.1% 12M change

Total Value Held $24.3 Million

Jason R Kelly Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 04 2024	SELL Open market or private sale	$155,000 $1.55 p/Share	100,000 Reduced 2.5%	3,894,680 Class A Common Stock
Jan 03 2024	SELL Open market or private sale	$154,000 $1.54 p/Share	100,000 Reduced 2.44%	3,994,680 Class A Common Stock
Dec 21 2023	SELL Open market or private sale	$174,000 $1.74 p/Share	100,000 Reduced 2.38%	4,094,680 Class A Common Stock
Dec 20 2023	SELL Open market or private sale	$179,000 $1.79 p/Share	100,000 Reduced 2.33%	4,194,680 Class A Common Stock
Dec 14 2023	SELL Open market or private sale	$163,587 $1.62 p/Share	100,980 Reduced 2.3%	4,294,680 Class A Common Stock
Dec 13 2023	SELL Open market or private sale	$132,686 $1.34 p/Share	99,020 Reduced 2.2%	4,395,660 Class A Common Stock
Dec 07 2023	SELL Open market or private sale	$131,000 $1.31 p/Share	100,000 Reduced 2.18%	4,494,680 Class A Common Stock
Dec 06 2023	SELL Open market or private sale	$132,000 $1.32 p/Share	100,000 Reduced 2.13%	4,594,680 Class A Common Stock
Nov 30 2023	SELL Open market or private sale	$135,000 $1.35 p/Share	100,000 Reduced 2.09%	4,694,680 Class A Common Stock
Nov 29 2023	SELL Open market or private sale	$145,000 $1.45 p/Share	100,000 Reduced 2.04%	4,794,680 Class A Common Stock
Nov 24 2023	SELL Open market or private sale	$141,000 $1.41 p/Share	100,000 Reduced 2.0%	4,894,680 Class A Common Stock
Nov 22 2023	SELL Open market or private sale	$140,000 $1.4 p/Share	100,000 Reduced 1.96%	4,994,680 Class A Common Stock
Nov 16 2023	SELL Open market or private sale	$145,000 $1.45 p/Share	100,000 Reduced 1.93%	5,094,680 Class A Common Stock
Nov 15 2023	SELL Open market or private sale	$154,000 $1.54 p/Share	100,000 Reduced 1.89%	5,194,680 Class A Common Stock
Nov 09 2023	SELL Open market or private sale	$129,000 $1.29 p/Share	100,000 Reduced 1.85%	5,294,680 Class A Common Stock
Nov 08 2023	SELL Open market or private sale	$150,000 $1.5 p/Share	100,000 Reduced 1.82%	5,394,680 Class A Common Stock
Nov 02 2023	SELL Open market or private sale	$152,000 $1.52 p/Share	100,000 Reduced 1.79%	5,494,680 Class A Common Stock
Nov 01 2023	SELL Open market or private sale	$134,000 $1.34 p/Share	100,000 Reduced 1.76%	5,594,680 Class A Common Stock
Oct 26 2023	SELL Open market or private sale	$146,000 $1.46 p/Share	100,000 Reduced 1.73%	5,694,680 Class A Common Stock
Oct 25 2023	SELL Open market or private sale	$148,000 $1.48 p/Share	100,000 Reduced 1.7%	5,794,680 Class A Common Stock
Oct 19 2023	SELL Open market or private sale	$161,000 $1.61 p/Share	100,000 Reduced 1.67%	5,894,680 Class A Common Stock
Oct 18 2023	SELL Open market or private sale	$169,000 $1.69 p/Share	100,000 Reduced 1.64%	5,994,680 Class A Common Stock
Oct 12 2023	SELL Open market or private sale	$166,000 $1.66 p/Share	100,000 Reduced 1.61%	6,094,680 Class A Common Stock
Oct 11 2023	SELL Open market or private sale	$176,000 $1.76 p/Share	100,000 Reduced 1.59%	6,194,680 Class A Common Stock
Oct 05 2023	SELL Open market or private sale	$167,000 $1.67 p/Share	100,000 Reduced 1.56%	6,294,680 Class A Common Stock

JRK

Jason R Kelly

Director

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DNA shares.

Notify only if

Value

Insider Trading

Get notified when an Ginkgo Bioworks Holdings, Inc. insider buys or sells DNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Ginkgo Bioworks Holdings, Inc.

Track Activities on DNA

Account